Terns Pharmaceuticals Inc

NASDAQ:TERN   3:59:54 PM EDT
7.29
-0.41 (-5.32%)
Earnings Announcements

Terns Pharmaceuticals Reports Qtrly Net Loss Per Share $0.47

Published: 11/15/2021 22:59 GMT
Terns Pharmaceuticals Inc (TERN) - Terns Pharmaceuticals Inc - Qtrly Net Loss per Share $0.47.
Terns Pharmaceuticals Inc - Expects Funds Will Be Sufficient to Support Its Planned Operating Expenses Into 2024.
Further Company Coverage: Terno ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.63

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.63

More details on our Analysts Page.